Artelo Biosciences, Inc. (ARTL) vs NexImmune, Inc. (NEXI)
- Artelo Biosciences, Inc. ARTL 2.70 −1.46%
- NexImmune, Inc. NEXI 0.00 NaN
Artelo Biosciences, Inc. and NexImmune, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and NexImmune, Inc. are of similar size ($1.6M and $1.5M). Across the 8 metrics below, NexImmune, Inc. leads on 6 and Artelo Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | ARTL | NEXI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (705.71%) | (232.97%) | (56.36%) |
| Return on assets | (234.30%) | (140.56%) | (48.04%) |
| Return on invested capital | (865.85%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack